Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M106,889Revenue $M40,159Net Margin (%)17.6Z-Score2.2
Enterprise Value $M132,125EPS $1.7Operating Margin %22.5F-Score6
P/E(ttm))17.5Cash Flow Per Share $0Pre-tax Margin (%)21.0Higher ROA y-yY
Price/Book14.310-y EBITDA Growth Rate %3.1Quick Ratio0.7Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %2.4Current Ratio1.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %-22.6ROA % (ttm)10.4Higher Current Ratio y-yN
Dividend Yield %5.9Insider Buy (3m)0ROE % (ttm)68.0Less Shares Outstanding y-yY
Payout Ratio %93.0Shares Outstanding M4,804ROI % (ttm)14.0Gross Margin Increase y-yN

Gurus Latest Trades with GLAXF

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

GLAXF is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


GLAXF: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29320.6view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$1285.42view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$1458.93view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$1285.42view

Press Releases about GLAXF :

    Quarterly/Annual Reports about GLAXF:

      News about GLAXF:

      Articles On GuruFocus.com
      Gilead Sciences Still has More Upside Jan 22 2015 
      Johnson & Johnson Riding High On Ebola Vaccines Jan 21 2015 
      set Jan 11 2015 
      tester Dec 18 2014 
      Weekly 3-Year Low Highlights: RDS.B, GSK, WPZ, CLR Dec 14 2014 
      Pfizer Spreading Its Wings Into A New Domain Of Life Sciences Dec 09 2014 
      The Top 5 European Stocks Held During Q3 Nov 25 2014 
      Jeff Auxier Buys Berkshire Hathaway in Third Quarter Nov 18 2014 
      Irving Kahn Starts New Position In GlaxoSmithKline Nov 13 2014 
      Irving Kahn Buys Stake in GlaxoSmithKline During Q3 2014 Nov 12 2014 

      More From Other Websites
      Novartis profits jump 12% on new drug sales Jan 27 2015
      Novartis looks to new drugs to fuel growth as restructuring gels Jan 27 2015
      Currency market swings hit global effort to fund vaccinations Jan 26 2015
      Vodafone payout helps dividends hit £97bn record Jan 25 2015
      WHO says cash crunch, rains could thwart Ebola efforts Jan 23 2015
      Ebola: British drug company ships experimental vaccine to Liberia Jan 23 2015
      GSK ships Ebola vaccine to west Africa Jan 23 2015
      US health officials say Ebola treatment trial to start soon in Liberia Jan 22 2015
      Vaccines group seeks $7.5 bln as disease fight reaches peak Jan 22 2015
      Hungry Actavis pauses to digest Allergan Jan 21 2015
      Self-doubt in snow boots: the reality of Davos for most CEOs Jan 19 2015
      Sacking the boss is no panacea for a shrivelling stock price Jan 18 2015
      J&J receives ?100m EU injection for Ebola vaccine development Jan 16 2015
      GSK's nicotine patches and gum feel the heat from e-cigarettes Jan 16 2015
      Researchers find clues on how melanoma resists effective treatments Jan 15 2015
      UK's FTSE falls as Swiss central bank unnerves stock markets Jan 15 2015
      Signs that Ebola "may be levelling off" in Sierra Leone - WHO Jan 07 2015
      Johnson & Johnson starts Ebola vaccine trial Jan 06 2015
      Britain's Vectura collaborates with Janssen in asthma, COPD Jan 06 2015
      Hikma shares jump on growth injection Jan 06 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK